Hologic Overview

  • Founded
  • 1985

Founded
  • Status
  • Public

  • Employees
  • 6,944

Employees
  • Stock Symbol
  • HOLX

Stock Symbol
  • Investments
  • 32

  • Share Price
  • $81.37

  • (As of Tuesday Closing)

Hologic General Information

Description

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Contact Information

Website
www.hologic.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
  • 250 Campus Drive
  • Marlborough, MA 01752
  • United States
+1 (508) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hologic Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$81.37 $82.15 $59.78 - $82.96 $20.3B 247M 1.63M $5.18

Hologic Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2022 30-Sep-2022 FY 2021 30-Sep-2021 FY 2020 30-Sep-2020
EV 16,576,820 16,576,820 21,023,604 19,790,549
Revenue 4,862,800 4,862,800 5,632,300 3,776,400
EBITDA 2,100,500 2,100,500 2,860,200 1,490,100
Net Income 1,302,000 1,302,000 1,871,500 1,115,200
Total Assets 9,071,200 9,071,200 8,919,900 7,195,800
Total Debt 2,921,600 2,921,600 3,144,600 3,147,200
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hologic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hologic‘s full profile, request access.

Request a free trial

Hologic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diag
Diagnostic Equipment
Marlborough, MA
6,944 As of 2022
00.000
000000000 00.000

000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
00000000 0000000
New York, NY
000 As of 0000
000.00
000000 - 000 000.00

000000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
0000000000 000000000
Brea, CA
00000 As of 0000
0.000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hologic Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angiodynamics Corporation New York, NY 000 000.00 000000 - 000 000.00
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
0000000 Formerly VC-backed Cape Town, South Africa 0 000 000000 - 000 000
00000000000 Corporation Waltham, MA 00000 00000000
0000 (0000000000 0 Venture Capital-Backed New York, NY 00 0000 00000000000 0000
You’re viewing 5 of 14 competitors. Get the full list »

Hologic Patents

Hologic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220361831-A1 Contrast-enhanced tomosynthesis with a copper filter Pending 17-May-2021 000000000
US-20220218294-A1 Systems and methods for applying force to breasts for imaging Pending 13-Jan-2021 0000000000
US-20220164951-A1 Systems and methods for using ai to identify regions of interest in medical images Pending 20-Nov-2020 00000000000
US-20220164586-A1 Systems and methods for using ai to identify regions of interest in medical images Pending 20-Nov-2020 00000000000
EP-3973881-A1 Light source for an imaging system and methods of the same Pending 24-Sep-2020 A61B6/502 0
To view Hologic’s complete patent history, request access »

Hologic Executive Team (49)

Name Title Board Seat Contact Info
Stephen Macmillan Chairman, President and Chief Executive Officer
Essex Mitchell President
Jan Verstreken President
Kevin Thornal President
Karleen Oberton Chief Financial Officer, Finance
You’re viewing 5 of 49 executive team members. Get the full list »

Hologic Board Members (12)

Name Representing Role Since
Amy Wendell Self Board Member 000 0000
Charles Dockendorff Hologic Board Member 000 0000
Christiana Stamoulis Self Board Member 000 0000
Ludwig Hantson Ph.D Hologic Board Member 000 0000
Namal Nawana Hologic Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Hologic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hologic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hologic‘s full profile, request access.

Request a free trial

Hologic Investments & Acquisitions (32)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 29-Nov-2021 0000000000 00000 Surgical Devices 0000000 0
00000000 17-Jun-2021 0000000000 00000 Diagnostic Equipment 0000000 0
000000000 01-Mar-2021 0000000000 00000 Biotechnology 0000000 0
0000000000000 22-Feb-2021 0000000000 00000 Laboratory Services (Healthcare) 00000 000
SOMATEX Medical Technologies 30-Dec-2020 Merger/Acquisition 000.00 Medical Supplies 00000000
You’re viewing 5 of 32 investments and acquisitions. Get the full list »

Hologic Subsidiaries (11)

Company Name Industry Location Founded
Diagenode Biotechnology Seraing, Belgium 2003
00000 00000000000 Diagnostic Equipment Danbury, CT 0000
00000000 Diagnostic Equipment Espoo, Finland 0000
000000 00000000000 Therapeutic Devices Newark, DE 0000
000000000000000 Laboratory Services (Healthcare) San Diego, CA 0000
You’re viewing 5 of 11 subsidiaries. Get the full list »

Hologic ESG

Risk Overview

Risk Rating

Updated November, 29, 2022

28.24 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,613

Rank

00.00

Percentile

Healthcare

Industry

00 of 635

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 228

Rank

00.00

Percentile

To view Hologic’s complete esg history, request access »

Hologic Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 0000000 28-Sep-2020 000000000000000000 00.00 Completed
  • 0000000
00000000 (00000000 22-Mar-2017 000000000000000000 00.000 Completed
  • 0000000
00000000 0000 04-Dec-2013 00000 00000 00 0000 Completed
  • 6 buyers
Sentinelle Medical 05-Aug-2010 Merger/Acquisition 00000 Completed
To view Hologic’s complete exits history, request access »